Diagnostik und Therapie maligner Ovarialtumoren 2005: Die Empfehlungen der Kommission Ovar der AGO
Standard
Diagnostik und Therapie maligner Ovarialtumoren 2005: Die Empfehlungen der Kommission Ovar der AGO. / Schmalfeldt, B; du Bois, A; Burges, A; Emons, G; Fink, D; Gropp, M; Hasenburg, A; Jäger, W; Kimmig, R; Kiechle, M; Kommoss, F; Kreienberg, R; Kuhn, W; Lück, H-J; Meier, W; Münstedt, K; Ortmann, O; Pfisterer, J; Richter, B; Runnebaum, I; Schröder, W; Sehouli, J; Tanner, B; Wagner, U; Weis, J.
In: Zentralblatt für Gynäkologie, Vol. 128, No. 1, 02.2006, p. 11-7.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Diagnostik und Therapie maligner Ovarialtumoren 2005: Die Empfehlungen der Kommission Ovar der AGO
AU - Schmalfeldt, B
AU - du Bois, A
AU - Burges, A
AU - Emons, G
AU - Fink, D
AU - Gropp, M
AU - Hasenburg, A
AU - Jäger, W
AU - Kimmig, R
AU - Kiechle, M
AU - Kommoss, F
AU - Kreienberg, R
AU - Kuhn, W
AU - Lück, H-J
AU - Meier, W
AU - Münstedt, K
AU - Ortmann, O
AU - Pfisterer, J
AU - Richter, B
AU - Runnebaum, I
AU - Schröder, W
AU - Sehouli, J
AU - Tanner, B
AU - Wagner, U
AU - Weis, J
PY - 2006/2
Y1 - 2006/2
N2 - Recommendations for diagnosis and treatment of malignant ovarian tumors with regard to the most recent data were worked out in a consensus process and valued by level of evidence (LoE) and grade of recommendation (GoR) of the Canadian Task Force for Preventive Health Care by the members of the Kommission Ovar der Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) in June 2005. A short version of these guidelines is presented.
AB - Recommendations for diagnosis and treatment of malignant ovarian tumors with regard to the most recent data were worked out in a consensus process and valued by level of evidence (LoE) and grade of recommendation (GoR) of the Canadian Task Force for Preventive Health Care by the members of the Kommission Ovar der Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) in June 2005. A short version of these guidelines is presented.
KW - Aged
KW - Combined Modality Therapy
KW - Evidence-Based Medicine
KW - Female
KW - Germany
KW - Humans
KW - Middle Aged
KW - Neoplasm Staging
KW - Ovarian Neoplasms
KW - Survival Rate
U2 - 10.1055/s-2006-921345
DO - 10.1055/s-2006-921345
M3 - SCORING: Zeitschriftenaufsatz
C2 - 16450281
VL - 128
SP - 11
EP - 17
IS - 1
ER -